{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T18:46:50Z","timestamp":1789152410546,"version":"build-2803163510"},"reference-count":104,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T00:00:00Z","timestamp":1712620800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Glob. Womens Health"],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>The evolution of contraception has been crucial for public health and reproductive well-being. Over the past 60 years, combined oral contraceptives (COCs) have remained an important part of the contraceptive landscape worldwide; continued development has worked toward maintaining efficacy and improving safety.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Seven global experts convened to discuss the clinical relevance of the oestrogen in COCs, focusing on the impact of the new oestrogen, oestetrol (E4). Participants then commented through an online forum on the summary content and other participants' feedback. We prepared this report to describe the experts' views, their follow-up from the open forum and the evidence supporting their views.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Ethinylestradiol (EE) and oestradiol (E2) affect receptors similarly whereas E4 has differential effects, especially in the liver and breast. Adequate oestrogen doses in COCs ensure regular bleeding and user acceptability. EE and E4 have longer half-lives than E2; accordingly, COCs with EE and E4 offer more predictable bleeding than those with E2. Oestrogen type and progestin influence VTE risk; E2 poses a lower risk than EE; although promising, E4\/DRSP VTE risk is lacking population-based data. COCs alleviate menstrual symptoms, impact mental health, cognition, libido, skin, and bone health.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Oestrogens play an important role in the contraceptive efficacy, bleeding patterns, and overall tolerability\/safety of COCs. Recent studies exploring E4 combined with DRSP show promising results compared to traditional formulations, but more definitive conclusions await further research.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fgwh.2024.1395863","type":"journal-article","created":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T04:31:55Z","timestamp":1712637115000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":20,"title":["Experts' view on the role of oestrogens in combined oral contraceptives: emphasis on oestetrol (E4)"],"prefix":"10.3389","volume":"5","author":[{"given":"M. D.","family":"Creinin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Cagnacci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Z.","family":"Spaczy\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Stute","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Chabbert-Buffet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Korver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Simoncini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,4,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1001\/jama.283.3.326","article-title":"Achievements in public health, 1900\u20131999: family planning","volume":"283","year":"2000","journal-title":"JAMA"},{"key":"B2","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S0140-6736(12)60478-4","article-title":"Maternal deaths averted by contraceptive use: an analysis of 172 countries","volume":"380","author":"Ahmed","year":"2012","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1016\/j.ajog.2011.06.056","article-title":"The state of hormonal contraception today: established and emerging noncontraceptive health benefits","volume":"205","author":"Maguire","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"B4","article-title":"The Economic Effects of Contraceptives Access: A Review of the Evidence","year":"2019"},{"key":"B5","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1783\/147118910793048665","article-title":"50 Years of \u201cthe pill\u201d: celebrating a golden anniversary","volume":"36","author":"Szarewski","year":"2010","journal-title":"J Fam Plan Reprod Heal Care"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ajog.2014.03.041","article-title":"The effects of reproductive hormones on the physical properties of cervicovaginal fluid","volume":"211","author":"Chappell","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"B7","volume-title":"Oral Contraceptive Pills","author":"Cooper","year":"2024"},{"key":"B8","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.contraception.2015.03.001","article-title":"Ovulatory effects of three oral contraceptive regimens: a randomized, open-label, descriptive trial","volume":"91","author":"Seidman","year":"2015","journal-title":"Contraception"},{"key":"B9","doi-asserted-by":"publisher","first-page":"827724","DOI":"10.3389\/fendo.2022.827724","article-title":"Estrogen receptor function: impact on the human endometrium","volume":"13","author":"Yu","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B10","first-page":"170","article-title":"The formulation of oral contraceptives: does the amount of estrogen make any clinical difference?","volume":"150","author":"Speroff","year":"1982","journal-title":"Johns Hopkins Med J"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/jcm11154634","article-title":"Bleeding patterns of oral contraceptives with a cyclic dosing regimen: an overview","volume":"11","author":"Archer","year":"2022","journal-title":"J Clin Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"430","DOI":"10.3109\/13625187.2011.614029","article-title":"Efficacy and tolerability of a monophasic combined oral contraceptive containing nomegestrol acetate and 17\u03b2-oestradiol in a 24\/4 regimen, in comparison to an oral contraceptive containing ethinylestradiol and drospirenone in a 21\/7 regimen","volume":"16","author":"Mansour","year":"2011","journal-title":"Eur J Contracept Reprod Heal Care"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1001\/jama.2021.21392","article-title":"Contraception selection, effectiveness, and adverse effects: a review","volume":"326","author":"Teal","year":"2021","journal-title":"JAMA"},{"key":"B14","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1097\/01.NAJ.0000654304.29632.a7","article-title":"An evidence-based update on contraception","volume":"120","author":"Britton","year":"2020","journal-title":"Am J Nurs"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1080\/09513590.2021.1963432","article-title":"Overall and bleeding-related discontinuation rates of a new oral contraceptive containing 4\u2005mg drospirenone only in a 24\/4 regimen and comparison to 0.075\u2005mg desogestrel","volume":"37","author":"Regidor","year":"2021","journal-title":"Gynecol Endocrinol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"242","DOI":"10.3109\/13625187.2016.1154144","article-title":"Women\u2019s preferences for menstrual bleeding frequency: results of the inconvenience due to women\u2019s monthly bleeding (ISY) survey","volume":"21","author":"Nappi","year":"2016","journal-title":"Eur J Contracept Reprod Heal Care"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12978-017-0439-6","article-title":"There might be blood: a scoping review on women\u2019s responses to contraceptive-induced menstrual bleeding changes","volume":"15","author":"Polis","year":"2018","journal-title":"Reprod Health"},{"key":"B18","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.contraception.2022.05.011","article-title":"Recommendations for standardization of bleeding data analyses in contraceptive studies","volume":"112","author":"Creinin","year":"2022","journal-title":"Contraception"},{"key":"B19","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.steroids.2014.06.012","article-title":"Estrogen receptors alpha and beta subtype-selective ligands and clinical potential","author":"Paterni","year":"2014","journal-title":"Steroids"},{"key":"B20","doi-asserted-by":"publisher","first-page":"110310","DOI":"10.1016\/j.contraception.2023.110310","article-title":"Comparison of estrogenic components used for hormonal contraception","author":"Stanczyk","year":"2024","journal-title":"Contraception"},{"key":"B21","article-title":"PubChem Compound Summary for CID 5991, Ethinylestradiol. Compound summary","year":"2022"},{"key":"B22","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.bbamcr.2005.03.012","article-title":"Differential effect of estrogen receptor alpha and beta agonists on the receptor for advanced glycation end product expression in human microvascular endothelial cells","volume":"1745","author":"Mukherjee","year":"2005","journal-title":"Biochim Biophys Acta"},{"key":"B23","article-title":"Ethinylestradiol. DrugBank Online","year":"2022"},{"key":"B24","doi-asserted-by":"publisher","first-page":"75","DOI":"10.2147\/OAJC.S179673","article-title":"Venous thrombosis and hormonal contraception: what\u2019s new with estradiol-based hormonal contraceptives?","volume":"9","author":"Fruzzetti","year":"2018","journal-title":"Open Access J Contracept"},{"key":"B25","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s11154-011-9182-4","article-title":"Metabolic effects of contraceptive steroids","volume":"12","author":"Sitruk-Ware","year":"2011","journal-title":"Rev Endocr Metab Disord"},{"key":"B26","first-page":"1","article-title":"Yasmin. Highlights of Prescribing Information","year":"2012"},{"key":"B27","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1177\/1076029616683802","article-title":"Oral contraceptives and HRT risk of thrombosis","volume":"24","author":"Gialeraki","year":"2018","journal-title":"Clin Appl Thromb"},{"key":"B28","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-030-11355-1_12","article-title":"Unique vascular benefits of estetrol, a native fetal estrogen with specific actions in tissues (NEST)","volume-title":"Sex Steroids\u2019 Effects on Brain, Heart and Vessels ISGE Series","author":"Foidart","year":"2019"},{"key":"B29","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.thromres.2020.05.008","article-title":"Estrogen and thrombosis: a bench to bedside review","volume":"192","author":"Abou-Ismail","year":"2020","journal-title":"Thromb Res"},{"key":"B30","doi-asserted-by":"publisher","first-page":"112804","DOI":"10.1016\/j.jenvman.2021.112804","article-title":"A review of 17\u03b1-ethynylestradiol (EE2) in surface water across 32 countries: sources, concentrations, and potential estrogenic effects","volume":"292","author":"Tang","year":"2021","journal-title":"J Environ Manage"},{"key":"B31","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.envint.2016.12.010","article-title":"Environmental impact of estrogens on human, animal and plant life: a critical review","volume":"99","author":"Adeel","year":"2017","journal-title":"Environ Int"},{"key":"B32","article-title":"Estradiol. DrugBank Online","year":"2022"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1161\/ATVBAHA.109.191221","article-title":"Estrogen receptors and endothelium","volume":"30","author":"Arnal","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"607","DOI":"10.2147\/PPA.S39371","article-title":"Nomegestrol acetate-17b-estradiol for oral contraception","volume":"7","author":"Burke","year":"2013","journal-title":"Patient Prefer Adherence"},{"key":"B35","article-title":"PubChem Compound Summary for CID 13791, Estradiol Valerate. Compound Summary","year":"2022"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10235625","article-title":"Estetrol: A New Choice for Contraception","volume":"10","author":"Fruzzetti","year":"2021","journal-title":"J Clin Med"},{"key":"B37","year":"2022"},{"key":"B38","year":"2021"},{"key":"B39","first-page":"399","article-title":"Estetrol, a fetal steroid for the treatment of adults","volume":"12","author":"Coelingh Bennink","year":"2015","journal-title":"J Reprod Med Endocrinol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"13","DOI":"10.53260\/EGO.213012","article-title":"Estetrol as estrogen in a combined oral contraceptive, from the first in-human study to the contraceptive efficacy","volume":"3","author":"Mawet","year":"2021","journal-title":"Eur Gynecol Obstet"},{"key":"B41","doi-asserted-by":"publisher","first-page":"217","DOI":"10.48095\/cccg2021217","article-title":"Estetrol and the possibilities of its clinical use","volume":"86","author":"K\u0159epelka","year":"2021","journal-title":"Ces Gynekol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1007\/s40268-023-00419-5","article-title":"Estetrol: from preclinical to clinical pharmacology and advances in the understanding of the molecular mechanism of action","author":"G\u00e9rard","year":"2023","journal-title":"Drugs R D"},{"key":"B43","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1080\/17512433.2022.2054413","article-title":"Profile of estetrol, a promising native estrogen for oral contraception and the relief of climacteric symptoms of menopause","volume":"15","author":"G\u00e9rard","year":"2022","journal-title":"Expert Rev Clin Pharmacol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/clpt.1988.7","article-title":"Pharmacokinetics of single and multiple doses of ethinyl estradiol and levonorgestrel in relation to smoking","volume":"43","author":"Kanarkowski","year":"1988","journal-title":"Clin Pharmacol Ther"},{"key":"B45","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.contraception.2012.12.011","article-title":"Ethinyl estradiol and 17\u03b2-estradiol in combined oral contraceptives: pharmacokinetics, pharmacodynamics and risk assessment","volume":"87","author":"Stanczyk","year":"2013","journal-title":"Contraception"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-022-01738-8","article-title":"Estetrol\/drospirenone: a review in oral contraception","author":"Lee","year":"2022","journal-title":"Drugs"},{"key":"B47","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1111\/aogs.14384","article-title":"Systemic hormonal contraception and risk of venous thromboembolism","volume":"101","author":"Heikinheimo","year":"2022","journal-title":"Acta Obstet Gynecol Scand"},{"key":"B48","doi-asserted-by":"publisher","first-page":"400","DOI":"10.3109\/09513590.2012.662547","article-title":"An overview of the development of combined oral contraceptives containing estradiol: focus on estradiol valerate\/dienogest","volume":"28","author":"Fruzzetti","year":"2012","journal-title":"Gynecol Endocrinol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/nrendo.2017.12","article-title":"The effects of oestrogens and their receptors on cardiometabolic health","volume":"13","author":"Morselli","year":"2017","journal-title":"Nat Rev Endocrinol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"463","DOI":"10.3109\/13625187.2015.1068934","article-title":"Unique effects on hepatic function, lipid metabolism, bone and growth endocrine parameters of estetrol in combined oral contraceptives","volume":"20","author":"Mawet","year":"2015","journal-title":"Eur J Contracept Reprod Heal Care"},{"key":"B51","doi-asserted-by":"publisher","first-page":"E19","DOI":"10.1152\/ajpendo.00211.2020","article-title":"Estetrol prevents western diet\u2013induced obesity and atheroma independently of hepatic estrogen receptor \u03b1","volume":"320","author":"Buscato","year":"2021","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms22041568","article-title":"Critical role of estrogens on bone homeostasis in both male and female: from physiology to medical implications","volume":"22","author":"Emmanuelle","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/13697137.2022.2139599","article-title":"Impact of estetrol (E4) on hemostasis, metabolism and bone turnover in postmenopausal women","year":"2022","journal-title":"Climacteric"},{"key":"B54","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1080\/13697130802073425","article-title":"Estetrol review: profile and potential clinical applications","volume":"11","author":"Coelingh Bennink","year":"2008","journal-title":"Climacteric"},{"key":"B55","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1093\/carcin\/bgu144","article-title":"Antiestrogenic effects of the fetal estrogen estetrol in women with estrogen-receptor positive early breast cancer","volume":"35","author":"Singer","year":"2014","journal-title":"Carcinogenesis"},{"key":"B56","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/978-3-319-70178-3_12","article-title":"Role of estrogens in the regulation of liver lipid metabolism","volume":"1043","author":"Palmisano","year":"2017","journal-title":"Adv Exp Med Biol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1080\/13697130802056511","article-title":"First human exposure to exogenous single-dose oral estetrol in early postmenopausal women","volume":"11","author":"Visser","year":"2008","journal-title":"Climacteric"},{"key":"B58","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.contraception.2016.08.018","article-title":"Reduced hemostatic effects with drospirenone-based oral contraceptives containing estetrol vs. ethinyl estradiol","volume":"95","author":"Kluft","year":"2017","journal-title":"Contraception"},{"key":"B59","doi-asserted-by":"publisher","first-page":"419","DOI":"10.3109\/13625187.2015.1044082","article-title":"A randomised study comparing the effect on ovarian activity of a progestogen-only pill (POP) containing desogestrel and a new POP containing drospirenone in a 24\/4 regimen","volume":"20","author":"Duijkers","year":"2015","journal-title":"Eur J Contracept Reprod Heal Care"},{"key":"B60","doi-asserted-by":"publisher","first-page":"5936","DOI":"10.1073\/pnas.97.11.5936","article-title":"Estrogen receptor (ER) beta, a modulator of ERalpha in the uterus","volume":"97","author":"Weihua","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B61","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.contraception.2016.04.015","article-title":"Bleeding pattern and cycle control with estetrol-containing combined oral contraceptives: results from a phase II, randomised, dose-finding study (FIESTA)","volume":"94","author":"Apter","year":"2016","journal-title":"Contraception"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fendo.2021.769187","article-title":"Combined oral contraceptives and venous thromboembolism: review and perspective to mitigate the risk","volume":"12","author":"Morimont","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B63","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.contraception.2020.08.015","article-title":"Evaluation of the effect of a new oral contraceptive containing estetrol and drospirenone on hemostasis parameters","volume":"102","author":"Douxfils","year":"2020","journal-title":"Contraception"},{"key":"B64","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1080\/13625187.2022.2029397","article-title":"Confirmation of the safety of combined oral contraceptives containing oestradiol on the risk of venous thromboembolism","volume":"27","author":"Grandi","year":"2022","journal-title":"Eur J Contracept Reprod Heal Care"},{"key":"B65","article-title":"Qlaira film-coated tablets. SmPC","year":"2022"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15761\/FWH.1000178","article-title":"Combined oral contraceptives containing dienogest and estradiol valerate may carry a lower risk of venous and arterial thromboembolism compared to conventional preparations: results from the extended INAS-SCORE study","volume":"5","author":"Dinger","year":"2020","journal-title":"Front Womens Health"},{"key":"B67","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1080\/13625187.2021.1987410","article-title":"Prospective controlled cohort study on the safety of a monophasic oral contraceptive containing nomegestrol acetate (2.5\u2005mg) and 17\u03b2-oestradiol (1.5\u2005mg) (PRO-E2 study): risk of venous and arterial thromboembolism","volume":"26","author":"Reed","year":"2021","journal-title":"Eur J Contracept Reprod Heal Care"},{"key":"B68","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/978-1-0716-3175-1_12","article-title":"Evaluation of activated protein C resistance using thrombin generation test","volume":"2663","author":"Douxfils","year":"2023","journal-title":"Methods Mol Biol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1111\/aogs.14428","article-title":"Combined oral contraceptives containing estradiol valerate vs ethinylestradiol on coagulation: a randomized clinical trial","volume":"101","author":"Haverinen","year":"2022","journal-title":"Acta Obstet Gynecol Scand"},{"key":"B70","doi-asserted-by":"publisher","first-page":"117","DOI":"10.2147\/OAJC.S97013","article-title":"Contraceptive options for women with premenstrual dysphoric disorder: current insights and a narrative review","volume":"7","author":"Lete","year":"2016","journal-title":"Open Access J Contracept"},{"key":"B71","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.contraception.2011.09.010","article-title":"An overview of four studies of a continuous oral contraceptive (levonorgestrel 90 mcg\/ethinyl estradiol 20 mcg) on premenstrual dysphoric disorder and premenstrual syndrome","volume":"85","author":"Freeman","year":"2012","journal-title":"Contraception"},{"key":"B72","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.contraception.2010.10.010","article-title":"Premenstrual dysphoric disorder symptom cluster improvement by cycle with the combined oral contraceptive ethinylestradiol 20 mcg plus drospirenone 3\u2005mg administered in a 24\/4 regimen","volume":"84","author":"Marr","year":"2011","journal-title":"Contraception"},{"key":"B73","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1093\/humupd\/dmi019","article-title":"ESHRE Capri Workshop Group. Noncontraceptive health benefits of combined oral contraception","volume":"11","year":"2005","journal-title":"Hum Reprod Update"},{"key":"B74","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/j.1744-4667.2012.00126.x","article-title":"Non-contraceptive uses and benefits of combined oral contraception","volume":"14","author":"Carey","year":"2012","journal-title":"Obstet Gynaecol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.ajog.2021.06.090","article-title":"Efficacy of combined oral contraceptives for depressive symptoms and overall symptomatology in premenstrual syndrome: pairwise and network meta-analysis of randomized trials","volume":"225","author":"de Wit","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/psb.837","article-title":"Qlaira: first COC licensed for heavy menstrual bleeding","volume":"22","author":"Chaplin","year":"2011","journal-title":"Prescriber"},{"key":"B77","article-title":"Yaz (drospirenone\/ethinyl estradiol) for Oral Contraception and Premenstrual Dysphoric Disorder. Drug Approval Package","year":"2006"},{"key":"B78","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/npp.2017.157","article-title":"Hormonal cycle and contraceptive effects on amygdala and salience resting-state networks in women with previous affective side effects on the pill","volume":"43","author":"Engman","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"B79","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.yhbeh.2014.08.011","article-title":"Estradiol and cognitive function: past, present and future","volume":"66","author":"Luine","year":"2014","journal-title":"Horm Behav"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fncel.2021.636176","article-title":"The impact of estrogen and estrogen-like molecules in neurogenesis and neurodegeneration: beneficial or harmful?","volume":"15","author":"Bustamante-Barrientos","year":"2021","journal-title":"Front Cell Neurosci"},{"key":"B81","doi-asserted-by":"publisher","first-page":"101565","DOI":"10.1016\/j.beem.2021.101565","article-title":"Cognitive health after menopause: does menopausal hormone therapy affect it?","volume":"35","author":"Stute","year":"2021","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"B82","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1016\/S0140-6736(08)60527-9","article-title":"Premenstrual syndrome","volume":"371","author":"Yonkers","year":"2008","journal-title":"Lancet"},{"key":"B83","first-page":"905","article-title":"Evaluation of extended and continuous use oral contraceptives","volume-title":"Ther Clin Risk Manag","author":"Wright","year":"2008"},{"key":"B84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/9701384","article-title":"The potential of hormonal contraception to influence female sexuality","volume":"2019","author":"de Castro Coelho","year":"2019","journal-title":"Int J Reprod Med"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12144740","article-title":"New Possibilities for Hormonal Vaginal Treatment in Menopausal Women","volume":"12","author":"Tomczyk","year":"2023","journal-title":"J Clin Med"},{"key":"B86","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.adengl.2019.06.008","article-title":"Oral contraceptives in dermatology","volume":"111","author":"Requena","year":"2020","journal-title":"Actas Dermo-Sifiliogr\u00e1ficas (English Ed)"},{"key":"B87","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.ijwd.2017.02.018","article-title":"A review of hormone-based therapies to treat adult acne vulgaris in women","volume":"3","author":"Trivedi","year":"2017","journal-title":"Int J Womens Dermatol"},{"key":"B88","article-title":"Dienogest\/ethinylestradiol can be used for acne after certain other treatments have failed. Vol. 44","year":"2017"},{"key":"B89","first-page":"173","article-title":"Approach to the management of idiopathic hirsutism","volume":"58","author":"Markovski","year":"2012","journal-title":"Can Fam Physician"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003987.pub5","article-title":"Combination contraceptives: effects on weight","volume":"2014","author":"Gallo","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"B91","doi-asserted-by":"publisher","first-page":"83334","DOI":"10.18632\/oncotarget.19833","article-title":"Antiandrogenic and antimineralocorticoid health benefits of COC containing newer progestogens: dienogest and drospirenone","volume":"8","author":"Regidor","year":"2017","journal-title":"Oncotarget"},{"key":"B92","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3390\/cells11081355","article-title":"Role of estrogens in menstrual migraine","volume":"11","author":"Nappi","year":"2022","journal-title":"Cells"},{"key":"B93","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13643-021-01618-4","article-title":"The complex relationship between estrogen and migraines: a scoping review","volume":"10","author":"Reddy","year":"2021","journal-title":"Syst Rev"},{"key":"B94","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.contraception.2022.10.004","article-title":"Tolerability and safety of the estetrol\/drospirenone combined oral contraceptive: Pooled analysis of two multicenter, open-label phase 3 trials","volume":"116","year":"2022","journal-title":"Contraception"},{"key":"B95","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1016\/j.ajpath.2017.07.013","article-title":"Estetrol, a fetal selective estrogen receptor modulator, acts on the vagina of mice through nuclear estrogen receptor \u03b1 activation","volume":"187","author":"Benoit","year":"2017","journal-title":"Am J Pathol"},{"key":"B96","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s10911-021-09497-0","article-title":"Estetrol and mammary gland: friends or foes?","volume":"26","author":"Gallez","year":"2021","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"B97","doi-asserted-by":"publisher","first-page":"CD006586","DOI":"10.1002\/14651858.CD006586.pub5","article-title":"Oral contraceptives containing drospirenone for premenstrual syndrome","volume":"6","author":"Ma","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"key":"B98","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1080\/13625187.2017.1336532","article-title":"Estetrol combined with drospirenone: an oral contraceptive with high acceptability, user satisfaction, well-being and favourable body weight control","volume":"22","author":"Apter","year":"2017","journal-title":"Eur J Contracept Reprod Heal Care"},{"key":"B99","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1007\/s00198-019-05103-6","article-title":"Bone health in estrogen-free contraception","volume":"2020","author":"Hadji","year":"2020","journal-title":"Osteoporos Int"},{"key":"B100","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1111\/j.1365-2265.2009.03688.x","article-title":"The effects of hormonal contraceptives on bone turnover markers and bone health","volume":"72","author":"Herrmann","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B101","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1095\/biolreprod.111.092593","article-title":"Diverse roles for sex hormone-binding globulin in reproduction","volume":"85","author":"Hammond","year":"2011","journal-title":"Biol Reprod"},{"key":"B102","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1080\/13697130701798692","article-title":"Oral bioavailability and bone-sparing effects of estetrol in an osteoporosis model","volume":"11","author":"Coelingh Bennink","year":"2008","journal-title":"Climacteric"},{"key":"B103","doi-asserted-by":"publisher","first-page":"28","DOI":"10.4274\/jcrpe.galenos.2019.2019.S0003","article-title":"Contraception for adolescents","volume":"12","author":"Todd","year":"2020","journal-title":"JCRPE J Clin Res Pediatr Endocrinol"},{"key":"B104","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.beem.2012.09.005","article-title":"Oral contraceptives in adolescent women","volume":"27","author":"Bitzer","year":"2013","journal-title":"Best Pract Res Clin Endocrinol Metab"}],"container-title":["Frontiers in Global Women's Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgwh.2024.1395863\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T04:32:02Z","timestamp":1712637122000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgwh.2024.1395863\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,9]]},"references-count":104,"alternative-id":["10.3389\/fgwh.2024.1395863"],"URL":"https:\/\/doi.org\/10.3389\/fgwh.2024.1395863","relation":{},"ISSN":["2673-5059"],"issn-type":[{"value":"2673-5059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,9]]},"article-number":"1395863"}}